Suppr超能文献

双位点端锚聚合酶抑制剂的解构为结合能提供了见解,并为配体优化指明了关键热点。

Deconstruction of Dual-Site Tankyrase Inhibitors Provides Insights into Binding Energetics and Suggests Critical Hotspots for Ligand Optimization.

作者信息

Sowa Sven T, Kücükdisli Murat, Mostinski Yelena, Schaller David A, Vinagreiro Carolina S, Cirillo Davide, Bosetti Chiara, Brinch Shoshy Alam, van Laar Kirsten, Wegert Anita, Leenders Ruben G G, Krauss Stefan, Waaler Jo, Volkamer Andrea, Lehtiö Lari, Nazaré Marc

机构信息

Faculty for Biochemistry and Molecular Medicine & Biocenter Oulu, University of Oulu, Aapistie 7, 90220 Oulu, Finland.

Medicinal Chemistry, Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Campus Berlin Buch, Robert-Roessle-Str. 10, 13125 Berlin, Germany.

出版信息

J Med Chem. 2025 Apr 10;68(7):7263-7279. doi: 10.1021/acs.jmedchem.4c02845. Epub 2025 Mar 25.

Abstract

Designing inhibitors is a complex task that requires a deep understanding of protein-ligand interactions and their dynamics. Ligands often interact with multiple binding subsites, with noncovalent interactions affecting binding affinity. Conformational changes and plasticity of both, the ligand and the protein influence binding energetics. We investigated the tankyrase ADP-ribosyltransferase as a promising drug target regulating many cellular pathways. Despite the existence of diverse tankyrase inhibitors, their binding energetics and contributions of flexible cryptic subpockets to binding affinity remain elusive. To examine these aspects, we deconstructed inhibitors to key fragments, dissected their energetic contribution to the affinity, and determined their binding mode by X-ray crystallography. Varying ligand efficiencies of the deconstructed, pocket-binding fragments revealed the cryptic nature of subpockets. These insights enabled us to redesign inhibitors with novel linkers, the observed key area for optimization, increasing the potency in enzymatic and cell-based assays by 7.5-fold and 6.2-fold compared to the parent ligand.

摘要

设计抑制剂是一项复杂的任务,需要深入了解蛋白质-配体相互作用及其动力学。配体通常与多个结合亚位点相互作用,非共价相互作用影响结合亲和力。配体和蛋白质的构象变化及可塑性都会影响结合能。我们研究了端锚聚合酶ADP-核糖基转移酶,它是一个有望调节多种细胞通路的药物靶点。尽管存在多种端锚聚合酶抑制剂,但其结合能以及柔性隐蔽亚口袋对结合亲和力的贡献仍不清楚。为了研究这些方面,我们将抑制剂解构为关键片段,剖析它们对亲和力的能量贡献,并通过X射线晶体学确定其结合模式。解构后的口袋结合片段具有不同的配体效率,揭示了亚口袋的隐蔽性质。这些见解使我们能够重新设计带有新型连接子的抑制剂,连接子是观察到的优化关键区域,与母体配体相比,在酶促和基于细胞的实验中,其效力提高了7.5倍和6.2倍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97d4/11997991/77d3d5bfcf45/jm4c02845_0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验